351 results on '"Castiglione, Vincenzo"'
Search Results
2. Disease features and management of cardiomyopathies in women
3. Sex differences in transthyretin cardiac amyloidosis
4. Biomarkers: Monoclonal Protein and Indicators of Cardiac Damage
5. Plasma Transthyretin and Its Ligands
6. Valvular heart disease in patients with cardiac amyloidosis
7. Effects of sacubitril-valsartan on remodelling, fibrosis and mitochondria in a murine model of isoproterenol-induced left ventricular dysfunction
8. Valve disease in cardiac amyloidosis: an echocardiographic score
9. The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis
10. Pathophysiology of Cardiac Amyloidosis
11. Safety and efficacy of levosimendan in patients with cardiac amyloidosis
12. Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction
13. Right heart failure in left heart disease: imaging, functional, and biochemical aspects of right ventricular dysfunction
14. Left Ventricular Diastolic Dysfunction
15. Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy
16. Abstract 15619: Prevalence of Transthyretin Cardiac Amyloidosis in Elderly Subjects From the General Population: The Catch Study
17. RNA-targeting and gene editing therapies for transthyretin amyloidosis
18. The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction
19. Current and emerging drug targets in heart failure treatment
20. Biomarkers for the diagnosis and management of heart failure
21. Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study.
22. [18F]-Florbetaben PET/CT holds prognostic value in cardiac AL amyloidosis
23. Beta-blocking patients with cardiac amyloidosis: Adelante cum juicio
24. Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis
25. Case Report: Role of numerical simulations in the management of acute aortic syndromes
26. Characterization of Phenotypic Variability in Becker Muscular Dystrophy for Clinical Practice and Towards Trial Readiness: A Two-Years Follow up Study
27. Cost-effectiveness of transthyretin cardiac amyloidosis screening and treatment: A Dilemma for the clinician
28. Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets
29. Myocardial salvage is increased after sympathetic renal denervation in a pig model of acute infarction
30. Safety and Tolerability of Neurohormonal Antagonism in Cardiac Amyloidosis
31. Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning
32. Rarefaction of Blood, But Not Lymphatic Capillaries, in Patients With Cardiac Amyloidosis
33. Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study.
34. Cachexia, sarcopenia and heart failure: A last mile to be walked
35. Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study
36. Sex differences in transthyretin cardiac amyloidosis
37. Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study
38. Different Continuous Training Intensities Improve Echocardiographic Parameters, Quality of Life, and Functional Capacity in Heart Failure Patients with Reduced Ejection Fraction
39. Diagnostic Tools: The Easier, the Better
40. Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan
41. Cardiovascular toxicity from therapies for light chain amyloidosis
42. Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis
43. Pathophysiological Rationale and Clinical Evidence for Neurohormonal Modulation in Heart Failure with Preserved Ejection Fraction
44. Risk Stratification in Transthyretin Cardiac Amyloidosis: The Added Value of Lung Spirometry
45. Role of Imaging in Cardiomyopathies
46. Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure
47. Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis
48. Head‐to‐head comparison between recommendations by the <scp>ESC</scp> and <scp>ACC</scp> / <scp>AHA</scp> / <scp>HFSA</scp> heart failure guidelines
49. Cardiac Richter’s syndrome: a rare case of chronic lymphocytic leukaemia transformation
50. Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.